google-site-verification: googlea69dc203c2776c21.html
top of page
Inicio: Bienvenido
Mesa de trabajo 2 copia.png

The Instituto de Investigaciones Clínicas Quilmes SRL is an institution dedicated exclusively to conducting outpatient clinical studies, in phase II, III and IV. With a vast experience of the staff in cardiological, rheumatological, oncological and diabetes studies, both in inpatients and outpatients. As well as training and continuous training in the area of clinical trials.

cdc-XLhDvfz0sUM-unsplash.jpg
hush-naidoo-yo01Z-9HQAw-unsplash.jpg
cdc-L0jLHqF7Q94-unsplash.jpg
Inicio: Texto
Captura de Pantalla 2021-06-02 a la(s) 1

El Sol newspaper

The Quilmes Clinical Research Institute will participate in the trials in Argentina that the German company Bayer will initiate for the application of the CureVac vaccine. To further develop the vaccine ...

Diario El Sol 3 feb.png

Diario El Sol

El Instituto de Investigaciones Clínicas Quilmes participará de los ensayos en la Argentina que iniciará la empresa alemana Bayer para la aplicación de la vacuna CureVac. Para llevar adelante el desarrollo de la vacuna...

Sur 02-02 feb.png

South Perspective Newspaper

The Quilmes Clinical Research Institute will participate in the trials in Argentina that the German company Bayer will initiate for the application of the CureVac vaccine. To further develop the vaccine ...

Press / News about the essay

bottom of page